Vaxart Retained Earnings Total Equity from 2010 to 2024
| VXRT Stock | USD 0.76 0.01 1.30% |
Retained Earnings Total Equity | First Reported 2011-06-30 | Previous Quarter -352.2 M | Current Value -374.8 M | Quarterly Volatility 77.5 M |
Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 M, Interest Expense of 1.4 M or Total Revenue of 7 M, as well as many indicators such as Price To Sales Ratio of 10.68, Dividend Yield of 0.0 or PTB Ratio of 2.42. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
Vaxart | Retained Earnings Total Equity |
Latest Vaxart's Retained Earnings Total Equity Growth Pattern
Below is the plot of the Retained Earnings Total Equity of Vaxart Inc over the last few years. It is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. Vaxart's Retained Earnings Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.
| Retained Earnings Total Equity | 10 Years Trend |
|
Retained Earnings Total Equity |
| Timeline |
Vaxart Retained Earnings Total Equity Regression Statistics
| Arithmetic Mean | (179,208,220) | |
| Coefficient Of Variation | (44.34) | |
| Mean Deviation | 66,859,064 | |
| Median | (163,800,000) | |
| Standard Deviation | 79,467,975 | |
| Sample Variance | 6315.2T | |
| Range | 248.5M | |
| R-Value | (0.51) | |
| Mean Square Error | 5030.3T | |
| R-Squared | 0.26 | |
| Significance | 0.05 | |
| Slope | (9,066,875) | |
| Total Sum of Squares | 88412.2T |
Vaxart Retained Earnings Total Equity History
About Vaxart Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Vaxart income statement, its balance sheet, and the statement of cash flows. Vaxart investors use historical funamental indicators, such as Vaxart's Retained Earnings Total Equity, to determine how well the company is positioned to perform in the future. Although Vaxart investors may use each financial statement separately, they are all related. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vaxart's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Vaxart Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Vaxart. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Retained Earnings Total Equity | -294.4 M | -279.7 M |
Pair Trading with Vaxart
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaxart position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxart will appreciate offsetting losses from the drop in the long position's value.Moving together with Vaxart Stock
| 0.81 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Vaxart Stock
| 0.47 | JPHLF | Japan Post Holdings | PairCorr |
| 0.35 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
| 0.35 | JPSTF | JAPAN POST BANK | PairCorr |
| 0.34 | ROIV | Roivant Sciences Financial Report 26th of June 2024 | PairCorr |
The ability to find closely correlated positions to Vaxart could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxart when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxart - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxart Inc to buy it.
The correlation of Vaxart is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaxart moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaxart Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vaxart can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Vaxart Stock Analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.